US Senate passes cannabis research bill, but House must weigh in
The U.S. Senate gave unanimous approval to a bipartisan bill to “cut the red tape” that stalls scientific research into the medical properties of cannabis and cannabidiols.
US Medical Marijuana Business News
The U.S. Senate gave unanimous approval to a bipartisan bill to “cut the red tape” that stalls scientific research into the medical properties of cannabis and cannabidiols.
Major multistate cannabis operators Cresco Labs and Columbia Care said Wednesday they have agreed to combine in a blockbuster deal worth roughly $2 billion, with Chicago-based Cresco set to acquire New York-headquartered Columbia.
The marijuana industry lost a staunch ally Friday when U.S. Rep. Don Young, the longest-serving member of the House of Representatives, died at age 88.
Is the U.S. marijuana industry evolving into a David-versus-Goliath confrontation?
A number of marijuana business officials and advocates characterize today’s cannabis industry as figurative warfare, pitting large companies seeking to dominate the market against smaller operators and entrepreneurs just wanting a foot in the door.
As the U.S. cannabis industry keeps growing, marijuana businesses, trade associations and political nonprofits are spending more and more money lobbying Congress on MJ reform and legalization.
The movement to overhaul federal marijuana policy has gotten more crowded in recent years, with new trade associations, business groups, social justice activists and lobbyists joining calls to legalize the plant.
The collection of stakeholders also has become much more diverse.
Small and minority-owned marijuana companies likely won’t survive without some help from Congress, an industry insider testified before a subcommittee hearing.